Literature DB >> 17121891

Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients.

Catherine F Poh1, Lewei Zhang, Don W Anderson, J Scott Durham, P Michele Williams, Robert W Priddy, Ken W Berean, Samson Ng, Olivia L Tseng, Calum MacAulay, Miriam P Rosin.   

Abstract

PURPOSE: Genetically altered cells could become widespread across the epithelium of patients with oral cancer, often in clinically and histologically normal tissue, and contribute to recurrent disease. Molecular approaches have begun to yield information on cancer/risk fields; tissue optics could further extend our understanding of alteration to phenotype as a result of molecular change. EXPERIMENTAL
DESIGN: We used a simple hand-held device in the operating room to directly visualize subclinical field changes around oral cancers, documenting alteration to fluorescence. A total of 122 oral mucosa biopsies were obtained from 20 surgical specimens with each biopsy being assessed for location, fluorescence visualization (FV) status, histology, and loss of heterozygosity (LOH; 10 markers on three regions: 3p14, 9p21, and 17p13).
RESULTS: All tumors showed FV loss (FVL). For 19 of the 20 tumors, the loss extended in at least one direction beyond the clinically visible tumor, with the extension varying from 4 to 25 mm. Thirty-two of 36 FVL biopsies showed histologic change (including 7 squamous cell carcinoma/carcinomas in situ, 10 severe dysplasias, and 15 mild/moderate dysplasias) compared with 1 of the 66 FV retained (FVR) biopsies. Molecular analysis on margins with low-grade or no dysplasia showed a significant association of LOH in FVL biopsies, with LOH at 3p and/or 9p (previously associated with local tumor recurrence) present in 12 of 19 FVL biopsies compared with 3 of 13 FVR biopsies (P=0.04).
CONCLUSIONS: These data have, for the first time, shown that direct FV can identify subclinical high-risk fields with cancerous and precancerous changes in the operating room setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121891     DOI: 10.1158/1078-0432.CCR-06-1317

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  76 in total

1.  Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Authors:  Marni Stott-Miller; John R Houck; Pawadee Lohavanichbutr; Eduardo Méndez; Melissa P Upton; Neal D Futran; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

2.  Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe.

Authors:  Richard A Schwarz; Wen Gao; Dania Daye; Michelle D Williams; Rebecca Richards-Kortum; Ann M Gillenwater
Journal:  Appl Opt       Date:  2008-02-20       Impact factor: 1.980

3.  Dynamics of cell transformation in culture and its significance for tumor development in animals.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

4.  Detection of Head and Neck Cancer in Surgical Specimens Using Quantitative Hyperspectral Imaging.

Authors:  Guolan Lu; James V Little; Xu Wang; Hongzheng Zhang; Mihir R Patel; Christopher C Griffith; Mark W El-Deiry; Amy Y Chen; Baowei Fei
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

Review 5.  Oncologic Procedures Amenable to Fluorescence-guided Surgery.

Authors:  Kiranya E Tipirneni; Jason M Warram; Lindsay S Moore; Andrew C Prince; Esther de Boer; Aditi H Jani; Irene L Wapnir; Joseph C Liao; Michael Bouvet; Nicole K Behnke; Mary T Hawn; George A Poultsides; Alexander L Vahrmeijer; William R Carroll; Kurt R Zinn; Eben Rosenthal
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

6.  Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Authors:  Nitin Nitin; Alicia L Carlson; Tim Muldoon; Adel K El-Naggar; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

7.  Clinical label-free biochemical and metabolic fluorescence lifetime endoscopic imaging of precancerous and cancerous oral lesions.

Authors:  Elvis Duran-Sierra; Shuna Cheng; Rodrigo Cuenca-Martinez; Bilal Malik; Kristen C Maitland; Y S Lisa Cheng; John Wright; Beena Ahmed; Jim Ji; Mathias Martinez; Moustafa Al-Khalil; Hussain Al-Enazi; Javier A Jo
Journal:  Oral Oncol       Date:  2020-04-02       Impact factor: 5.337

8.  New hope for an oral cancer solution: together we can make a difference.

Authors:  Miriam P Rosin; Catherine F Poh; J Mark Elwood; P Michele Williams; Richard Gallagher; Calum MacAulay; Wan W Lam; Ajit Auluck; Lewei Zhang; T Gregory Hislop
Journal:  J Can Dent Assoc       Date:  2008-04       Impact factor: 1.316

Review 9.  Critical evaluation of diagnostic aids for the detection of oral cancer.

Authors:  Mark W Lingen; John R Kalmar; Theodore Karrison; Paul M Speight
Journal:  Oral Oncol       Date:  2007-09-06       Impact factor: 5.337

10.  Clinical application of fluorescence endoscopic imaging using hypericin for the diagnosis of human oral cavity lesions.

Authors:  P S P Thong; M Olivo; W W L Chin; R Bhuvaneswari; K Mancer; K-C Soo
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.